| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/23/2006 | US20060041113 Phytase enzymes, nucleic acids encoding phytase enzymes and vectors and host cells incorporating same |
| 02/23/2006 | US20060041112 Novel human G-coupled protein receptor kinases and polynucleotides encoding the same |
| 02/23/2006 | US20060041058 combined with bioactive agents for a variety of purposes including drug delivery and conjugation to one member of a binding pair for use in an assay |
| 02/23/2006 | US20060040877 Capable of functioning in Saccharopolyspora spinosa; for controlling insects |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040850 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states |
| 02/23/2006 | US20060040373 Papermaking, food, agriculture; genetic engineered polynucleotide; degradation of plant cell wall components; decomposition of plants and fruits |
| 02/23/2006 | US20060040372 GANP protein |
| 02/23/2006 | US20060040371 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 02/23/2006 | US20060040370 Purified thermostable pyrococcus furiosus dna polymerase i |
| 02/23/2006 | US20060040357 Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 02/23/2006 | US20060040355 Mutated Tn5 transposase proteins and the use thereof |
| 02/23/2006 | US20060040353 Production of galactosylated glycoproteins in lower eukaryotes |
| 02/23/2006 | US20060040351 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/23/2006 | US20060040348 Methods for producing and purifying recombinant alpha-L-iduronidase |
| 02/23/2006 | US20060040346 Bacterial bioreactor for propagation of enzymatic polypeptides |
| 02/23/2006 | US20060040345 Deglycosylated enzymes for conjugates |
| 02/23/2006 | US20060040343 Identification of 3-Ketosteroid 9-Alfa-hydroxylase genes and microorganisms blocked in 3-Ketosteroid 9-Alfa-hydroxylase activity |
| 02/23/2006 | US20060040336 Containing an acetylated substrate peptide labeled with a substance which emits a signal; and a peptidase whose peptide-cleaving activity changes upon an acetylation level of the substrate peptide. |
| 02/23/2006 | US20060040317 Recombinant Corynebacteria glutamicum in which expression of endogenous mqo gene coding for malate quinone oxidoreductase is eliminated by mutagenesis; Escherichia coli strain DH5alphamcr/pXK99Emobmqo (=DH5 alpha mcr/pXK99Emobmqo); especially L-lysine |
| 02/23/2006 | US20060040316 Using transforming growth factor-beta -activated kinase-1 (TAK-1) and TAK1 binding protein 1(TAB-1) as evaluative tool in detection of modulators of interleukin and tumor necrosis factor activities |
| 02/23/2006 | US20060040310 Epitope testing using soluble HLA |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040306 81588 methods and compositions of human proteins and uses thereof |
| 02/23/2006 | US20060040295 Novel allelic variant of CYP2C19 associated with drug metabolism |
| 02/23/2006 | US20060040294 Cleavage of nucleic acids |
| 02/23/2006 | US20060040289 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/23/2006 | US20060040281 Polyhydroxybutyrate polymerase |
| 02/23/2006 | US20060040279 DNA chips used for bioprocess control |
| 02/23/2006 | US20060040267 Transcriptional activator |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |
| 02/23/2006 | US20060040260 Composition and method for monitoring in vitro conversion of full -length mammalian prion protein to amyloid form with physical properties of PRPsc |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | US20060039905 Galectin 11 |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | DE10335447B4 Aminooxidase Amino oxidase |
| 02/23/2006 | CA2592521A1 Modified vitamin k dependent polypeptides |
| 02/23/2006 | CA2577213A1 Use of gsk-3 inhibitors for the treatment of prostate cancer |
| 02/23/2006 | CA2577039A1 Aqueous enzyme delivery system |
| 02/22/2006 | EP1627920A1 Method for the manufacture of recombinant trypsin |
| 02/22/2006 | EP1627885A1 Polypeptide capable of assisting digestive organ absorption |
| 02/22/2006 | EP1627884A1 Process for producing dipeptides |
| 02/22/2006 | EP1627640A1 Sulfate group transferase inhibitor |
| 02/22/2006 | EP1627217A2 Cdkl1 as modifier of branching morphogenesis and methods of use |
| 02/22/2006 | EP1627068A2 Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds |
| 02/22/2006 | EP1627066A2 Functional characterization of myo-inositol monophosphatase |
| 02/22/2006 | EP1627065A1 Modification of fatty acid biosynthesis using recombinant diacylglycerol acyltransferase sequences from ryegrass ( lolium ) and fescue ( festuca ) |
| 02/22/2006 | EP1627059A2 Recombinant comamonas testosteroni 5-mgam-4d; amids and carboxylic acid production |
| 02/22/2006 | EP1627058A2 Bioreactor containing cells expressing glycosyltransferase nucleic acids |
| 02/22/2006 | EP1627051A2 Regulation of acheron expression |
| 02/22/2006 | EP1627050A2 Variant humicola grisea cbh1.1 |
| 02/22/2006 | EP1627049A2 Novel trichoderma genes |
| 02/22/2006 | EP1627047A2 Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using high molecular weight hyaluronic acid |
| 02/22/2006 | EP1627045A2 Pyk2 crystal structure and uses |
| 02/22/2006 | EP1627043A2 Mapk7 as modifier of branching morphogenesis and methods of use |
| 02/22/2006 | EP1627042A2 Map2k6 as modifier of branching morphogenensis and methods of use |
| 02/22/2006 | EP1626988A2 Intron fusion proteins, and methods of identifying and using same |
| 02/22/2006 | EP1626979A2 Genetically modified yeast species and fermentation processes using genetically modified yeast |
| 02/22/2006 | EP1539940A4 Ribonuclease zymogen design |
| 02/22/2006 | EP1513392A4 A method for increasing resistance of monocot plants against abiotic stresses |
| 02/22/2006 | EP1481080A4 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics |
| 02/22/2006 | EP1463750A4 Plant cyclopropane fatty acid synthase genes, proteins and uses thereof |
| 02/22/2006 | EP1436402B1 Coffee plant with reduced alpha-d-galactosidase activity |
| 02/22/2006 | EP1434882A4 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 02/22/2006 | EP1263286B1 Methods for extending the freshness of cut flowers |
| 02/22/2006 | EP1131418B1 Alpha-amylase variants |
| 02/22/2006 | EP1047788B1 Method of determining metastatic potential employing the asp1 gene |
| 02/22/2006 | EP1003844B1 Kinase activating dependent cyclin protein kinases, and their uses |
| 02/22/2006 | EP1000161B1 Anticoagulant fusion protein anchored to cell membrane |
| 02/22/2006 | EP0907723B1 Enzyme composition for tissue dissociation |
| 02/22/2006 | EP0796912B1 Novel lysine decarboxylase gene and process for producing l-lysine |
| 02/22/2006 | EP0722490B1 Amylase variants |
| 02/22/2006 | EP0549615B1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 02/22/2006 | CN1738899A 洗涤剂组合物 Detergent composition |
| 02/22/2006 | CN1738898A Antimicrobial activity of antibodies producing reactive oxygen species |
| 02/22/2006 | CN1738888A Antioxidant, skin preparation for external use, cosmetic and food |
| 02/22/2006 | CN1738636A Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases wit |
| 02/22/2006 | CN1737145A Lotus polyphenol oxidase gene sequence and its uses |
| 02/22/2006 | CN1737135A Method for nanometer fixed enzyme directionally producing TF2A crude extract in vitro |
| 02/22/2006 | CN1737134A High purity kallidinogenase prepartion method and its pharmaceutical formulation |
| 02/22/2006 | CN1737133A High purity venom fibrinolysin prepartion method and its pharmaceutical formulation |
| 02/22/2006 | CN1737132A Method for quick preparing glycosyl transferred beta-galactosidase |
| 02/22/2006 | CN1243096C Recombined D-hydantoin enzyme and application thereof |
| 02/22/2006 | CN1243095C Extracting process of actinidia proteinase |
| 02/21/2006 | US7002057 Thioredoxin H homologs |
| 02/21/2006 | US7002001 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection |
| 02/21/2006 | US7001998 Nucleic acids encoding a chimeric glycosyltransferase |
| 02/21/2006 | US7001997 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits |
| 02/21/2006 | US7001994 Coupling monosaccharide into glucoprotein |
| 02/21/2006 | US7001993 site-directed mutagenesis; high protease-inhibitory activity in absence of heparin |
| 02/21/2006 | US7001986 Fluorescent proteins |
| 02/21/2006 | US7001772 Product and process for transformation of Thraustochytriales microorganisms |
| 02/21/2006 | US7001771 Genes encoding wheat starch synthases and uses thereof |
| 02/21/2006 | US7001764 Compositions comprising tissue specific adenoviral vectors |
| 02/21/2006 | US7001762 Neurospora crassa (N. crassa); nucleotide sequences; vectors and host cells; silencing gene has a RNA-dependent RNA polymerase domain; use to study gene silencing as it pertains to expression of transgenes |
| 02/21/2006 | US7001757 Protein |
| 02/21/2006 | US7001753 59079 and 12599, protein kinase family members and uses therefor |
| 02/21/2006 | US7001752 Murine and human kinases |
| 02/21/2006 | US7001751 PyrF gene and the utilization thereof |
| 02/21/2006 | US7001748 Preparation of polyketide synthase; obtain nucleotide sequences coding enzymatic polypeptide, express sequences, monitor efficiency of polypeptide |